Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.

Young-Won LeeSei-Hyun AhnYoung-Jin LeeTae-Kyung YooJisun KimIl Yong ChungHee Jeong KimBeom Seok KoJong Won LeeByung Ho SonSae Byul Lee

Published in: PloS one (2023)

The decision regarding adjuvant therapy should be made considering clinical and genomic risks and age, and clinicians should consult with patients about adverse effects and compliance.

Keyphrases

end stage renal disease
ejection fraction
palliative care
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
postmenopausal women
cross sectional
gene expression
patient reported outcomes
decision making
copy number
patient reported